What You Should Know:
– LabConnect, a global provider of central laboratory services, has announced a strategic collaboration with OmniScience, the AI company behind the Vivo platform.
– Together, the companies will deliver an AI Agentic solution to give sponsors intelligent, real-time insights from clinical trial lab data.
Transforming Lab Data into Real-Time Action
Clinical trial lab data is often complex, siloed, and delayed, which can lead to slow decision-making and increased risk. By combining LabConnect’s expertise in central lab testing with OmniScience’s Vivo platform, trial sponsors can now unify fragmented lab datasets, automate oversight, and surface risk signals. This collaboration aims to accelerate trial timelines and improve outcomes.
Vivo is an AI-native clinical trial intelligence platform that unifies disparate data sources to provide real-time insights. The platform functions as a “control tower” to equip clinical, operational, safety, and data science teams with the clarity they need to act faster and more confidently.
Vivo-Lab, a specialized implementation of Vivo, brings this same intelligence to laboratory data. It streamlines lab workflows by surfacing critical trends, anomalies, and site-level discrepancies as they happen, helping teams move from reactive to proactive oversight.
“Our mission at OmniScience is to help trial teams see and act faster,” said Angela Holmes, CEO and Co-Founder of OmniScience. “Partnering with LabConnect extends that vision by transforming lab data into real time actionable intelligence that sponsors can trust”.
